RESEARCH PAPER
Relationship between salivary stress biomarker levels and cigarette smoking in healthy young adults: an exploratory analysis
 
More details
Hide details
1
Department of Preventive and Public Health Dentistry, Fukuoka Dental College, Fukuoka, Japan
2
Department of General Dentistry, Fukuoka Dental College, Fukuoka, Japan
CORRESPONDING AUTHOR
Nao Suzuki   

Department of Preventive and Public Health Dentistry, Fukuoka Dental College, 2-15-1 Tamura, Sawara-ku, Fukuoka 814-0193, Japan
Publish date: 2016-06-06
 
Tobacco Induced Diseases 2016;14(June):20
KEYWORDS
ABSTRACT
Background:
This study investigated the relationships among salivary stress biomarkers, cigarette smoking, and mood states.

Methods:
The study population comprised 49 healthy sixth-year dental students at Fukuoka Dental College (39 men, 10 women; age, 23–31 years). Lifetime exposure to smoking was calculated using the Brinkman index (BI). Resting saliva samples were collected, and concentrations of cortisol, secretory immunoglobulin A (SIgA), interleukin (IL)-1β, interleukin-6, and tumor necrosis factor (TNF)-α were determined. Mood states (tension-anxiety, depression-dejection, anger-hostility, fatigue, confusion, and vigor) over the previous week were assessed using the Profile of Mood States - Brief Japanese Version.

Results:
Salivary IL-1β levels were significantly higher in smokers than non-smokers (P = 0.044), regardless of the BI or mood state. A significant positive correlation was evident between the TNF-α level and the BI (P = 0.036), and the SIgA level was positively correlated with the BI (P = 0.067) but did not reach statistical significance. In terms of mood states, higher fatigue scores and lower vigor scores were observed in smokers. The TNF-α level and vigor score were negatively correlated (r = –0.229, P = 0.135), but the correlation did not reach statistical significance. However, the SIgA level and fatigue score were significantly positively correlated (r = 0.410, P = 0.005).

Conclusions:
The TNF-α and SIgA levels were both positively correlated with the BI. Furthermore, the TNF-α level was negatively correlated with the vigor score, whereas the SIgA level was positively correlated with the fatigue score. Thus, salivary levels of TNF-α and SIgA may be used as biomarkers of mood states in healthy young smokers.

 
REFERENCES (42)
1.
Filder JA, West R. Self-perceived smoking motives and their correlates in a general population sample. Nicotine Tob Res. 2009;11:1182–8.
 
2.
McEwen A, West R, McRobbie H. Motives for smoking and their correlates in clients attending Stop Smoking treatment services. Nicotine Tob Res. 2008;10:843–50.
 
3.
Buchmann AF, Laucht M, Schmid B, Wiedemann K, Mann K, Zimmermann US. Cigarette craving increases after a psychosocial stress test and is related to cortisol stress responses but not to dependence scores in daily smokers. J Psychopharmacol. 2010;24:247–55.
 
4.
Perkins KA, Grobe JE. Increased desire to smoke during acute stress. Br J Addict. 1992;87:1037–40.
 
5.
Flory K, Hankin BL, Kloos B, Cheely C, Turecki G. Alcohol and cigarette use and misuse among Hurricane Katrina survivors: psychosocial risk and protective factors. Subst Use Misuse. 2009;44:1711–24.
 
6.
Nandi A, Galea S, Ahern J, Vlahov D. Probable cigarette dependence, PTSD, and depression after an urban disaster: results from a population survey of New York City residents 4 months after September 11, 2001. Psychiatry. 2005;68:299–310.
 
7.
Parslow RA, Jorm AF. Tobacco use after experiencing a major natural disaster: analysis of a longitudinal study of 2063 young adults. Addiction. 2006;101:1044–50.
 
8.
Bakhshaie J, Zvolensky MJ, Goodwin RD. Cigarette smoking and the onset and persistence of depression among adults in the United States: 1994–2005. Compr Psychiatry. 2015;60:142–8.
 
9.
Dierker L, Rose J, Selya A, Piasecki TM, Hedeker D, Mermelstein R. Depression and nicotine dependence from adolescence to young adulthood. Addict Behav. 2015;41:124–8.
 
10.
Patten CA, Gillin JC, Golshan S, Wolter TD, Rapaport M, Kelsoe J. Relationship of mood disturbance to cigarette smoking status among 252 patients with a current mood disorder. J Clin Psychiatry. 2001;62:319–24.
 
11.
Silverman MN, Pearce BD, Biron CA, Miller AH. Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection. Viral Immunol. 2005;18:41–78.
 
12.
Stein EA, Pankiewicz J, Harsch HH, Cho JK, Fuller SA, Hoffmann RG, Hawkins M, Rao SM, Bandettini PA, Bloom AS. Nicotine-induced limbic cortisol activation in the human brain: a functional MRI study. Am J Psychiatry. 1998;155:1009–15.
 
13.
Wong JA, Pickworth WB, Waters AJ, al’Absi M, Leventhal AM. Cortisol levels decrease after acute tobacco abstinence in regular smokers. Hum Psychopharmacol. 2014;29:152–62.
 
14.
Booij SH, Bos EH, Bouwmans ME, van Faassen M, Kema IP, Oldehinkel AJ, de Jonge P. Cortisol and α-amylase secretion patterns between and within depressed and non-depressed individuals. Plos One. 2015;10:e0131002.
 
15.
Laurent HK, Stroud LR, Brush B, D’Angelo C, Granger DA. Secretory IgA reactivity to social threat in youth: relations with HPA, ANS, and behavior. Psychoneuroendocrinology. 2015;59:81–90.
 
16.
Ng V, Koh D, Ong HY, Chia SE, Ong CN. Are salivary immunoglobulin A and lysozyme biomarkers of stress among nurses? J Occup Environ Med. 1999;41:920–7.
 
17.
Giuca MR, Pasini M, Tecco S, Giuca G, Marzo G. Levels of salivary immunoglobulins and periodontal evaluation in smoking patients. BMC Immunol. 2014;15:5.
 
18.
Golpasand Hagh L, Zakavi F, Ansarifar S, Ghasemzadeh O, Solgi G. Association of dental caries and salivary sIgA with tobacco smoking. Aust Dent J. 2013;58:219–23.
 
19.
Norhagen Engström G, Engström PE. Effects of tobacco smoking on salivary immunoglobulin levels in immunodeficiency. Eur J Oral Sci. 1998;106:986–91.
 
20.
Kunz-Ebrecht SR, Mohamed-Ali V, Feldman PJ, Kirschbaum C, Steptoe A. Cortisol responses to mild psychological stress are inversely associated with proinflammatory cytokines. Brain Behav Immun. 2003;17:373–83.
 
21.
Ojima M, Hanioka T. Destructive effects of smoking on molecular and genetic factors of periodontal disease. Tob Induc Dis. 2010;8:4.
 
22.
Toker H, Akpıner A, Aydın H, Poyraz O. Influence of smoking on interleukin-1beta level, oxidant status and antioxidant status in gingival crevicular fluid from chronic periodontitis patients before and after periodontal treatment. J Periodontal Res. 2012;47:572–7.
 
23.
Kamma JJ, Giannopoulou C, Vasdekis VG, Mombelli A. Cytokine profile in gingival crevicular fluid of aggressive periodontitis: influence of smoking and stress. J Clin Periodontol. 2004;31:894–902.
 
24.
Rawlinson A, Grummitt JM, Walsh TF, Ian Douglas CW. Interleukin 1 and receptor antagonist levels in gingival crevicular fluid in heavy smokers versus non-smokers. J Clin Periodontol. 2003;30:42–8.
 
25.
Boström L, Linder LE, Bergström J. Smoking and crevicular fluid levels of IL-6 and TNF-α in periodontal disease. J Clin Periodontol. 1999;26:352–7.
 
26.
Hanioka T, Ojima M, Tanaka K, Aoyama H. Relationship between smoking status and tooth loss: findings from national databases in Japan. J Epidemiol. 2007;17:125–32.
 
27.
Brinkman GL, Coates Jr EO. The effect of bronchitis, smoking, and occupation on ventilation. Am Rev Respir Dis. 1963;87:684–93.
 
28.
Shacham S. A shortened version of the Profile of Mood States. J Pers Assess. 1983;47:305–6.
 
29.
Gursoy UK, Könönen E, Uitto VJ, Pussinen PJ, Hyvärinen K, Suominen-Taipale L, Knuuttila M. Salivary interleukin-1β concentration and the presence of multiple pathogens in periodontitis. J Clin Periodontol. 2009;36:922–7.
 
30.
Michaud M, Balardy L, Moulis G, Gaudin C, Peyrot C, Vellas B, Cesari M, Nouthashemi F. Proinflammatory cytokines, aging, and age-related diseases. J Am Med Dir Assoc. 2013;14:877–82.
 
31.
Rathnayake N, Åkerman S, Klinge B, Lundegren N, Jansson H, Tryselius Y, Sorsa T, Gustafsson A. Salivary biomarkers of oral health–a cross-sectional study. J Clin Periodontol. 2013;40:140–7.
 
32.
Nishida N, Yamamoto Y, Tanaka M, Maeda K, Kataoka K, Nakayama K, Morimoto K, Shizukuishi S. Association between passive smoking and salivary markers related to periodontitis. J Clin Periodontol. 2006;33:717–23.
 
33.
Diez-Pina JM, Fernandez-Aceñero MJ, Llorente-Alonso MJ, Diaz-Lobato S, Mayoralas S, Florez A. Tumor necrosis factor alpha as a marker of systemic and local inflammation in “healthy” smokers. Int J Gen Med. 2009;2:9–14.
 
34.
Petrescu F, Voican SC, Silosi I. Tumor necrosis factor-α serum levels in healthy smokers and nonsmokers. Int J Chron Obstruct Pulmon Dis. 2010;5:217–22.
 
35.
Blume J, Douglas SD, Evans DL. Immune suppression and immune activation in depression. Brain Behav Immun. 2011;25:221–9.
 
36.
Berthold-Losleben M, Himmerich H. The TNF-α system: functional aspects in depression, narcolepsy and psychopharmacology. Curr Neuropharmacol. 2008;6:193–202.
 
37.
Cavadini G, Petrzilka S, Kohler P, Jud C, Tobler I, Birchler T, Fontana A. TNF-α suppresses the expression of clock genes by interfering with E-box-mediated transcription. Proc Natl Acd Sci USA. 2007;104:12843–8.
 
38.
Mao GX, Lan XG, Cao YB, Chen ZM, He ZH, Lv YD, Wang YZ, Hu XL, Wang GF, Yan J. Effects of short-term bathing on human health in a broad-leaved evergreen forest in Zhejiang Province, China. Biomed Environ Sci. 2012;25:317–24.
 
39.
Campisi J, Bravo Y, Cole J, Gobeil K. Acute psychological stress differentially influences salivary endocrine and immune measures in undergraduate students. Physiol Behav. 2012;107:317–21.
 
40.
Avşar A, Darka O, Bodrumlu EH, Bek Y. Evaluation of the relationship between passive smoking and salivary electrolytes, protein, secretory IgA, sialic acid and amylase in young children. Arch Oral Biol. 2009;54:457–63.
 
41.
Prodan A, Brand HS, Lightenberg AJ, Imangaliyav S, Tsivtsivadze E, van der Weijden F, Crielaard W, Keijser BJ, Veerman EC. Eur J Oral Sci. 2015;123:149–57.
 
42.
Izawa S, Miki K, Liu X, Ogawa N. The diurnal patterns of salivary interleukin-6 and C-reactive protein in healthy young adults. Brain Behav Immun. 2013;27:38–41.
 
 
CITATIONS (5):
1.
The Potential Roles of Extracellular Vesicles in Cigarette Smoke-Associated Diseases
A-Reum Ryu, Do Hyun Kim, Eunjoo Kim, Mi Young Lee
Oxidative Medicine and Cellular Longevity
 
2.
Clinical and radiographic periodontal status and whole salivary cotinine, IL-1β and IL-6 levels in cigarette- and waterpipe-smokers and E-cig users
Sameer A. Mokeem, Mohammed N. Alasqah, Dimitrios Michelogiannakis, Abdulaziz A. Al-Kheraif, Georgios E. Romanos, Fawad Javed
Environmental Toxicology and Pharmacology
 
3.
Smoking Dependent Alterations in Bone Formation and Inflammation Represent Major Risk Factors for Complications Following Total Joint Arthroplasty
Sabrina Ehnert, Romina Aspera-Werz, Christoph Ihle, Markus Trost, Barbara Zirn, Ingo Flesch, Steffen Schröter, Borna Relja, Andreas Nussler
Journal of Clinical Medicine
 
4.
Effects of active and passive smoking on salivary cytokines levels in rats: A pilot study
Sheng Ge, Pei Ye, Guo-Yang Li, Yi-Fu Fu, Qian Zhou, Fan Huang, Xiang Wang, Wen-Mei Wang
Toxicology and Industrial Health
 
5.
Association between leukocyte telomere length and hostility in US army service members
Lei Zhang, Xian-Zhang Hu, Dale Russell, David Benedek, Carol Fullerton, James Naifeh, Xiaoxia Li, Ze Chen, Hongyan Wu, Tsz Ng, Pablo Aliaga, Tzu-Cheg Kao, Tianzheng Yu, Jacob Dohl, Gary Wynn, Robert Ursano
Neuroscience Letters
 
eISSN:1617-9625